- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01791335
NIV and Glottis-diaphragm Synchrony
June 9, 2015 updated by: Leo Heunks, University Medical Center Nijmegen
Effect of Noninvasive Ventilation on the Synchrony of the Upper Airways and Inspiration.
Noninvasive ventilation (NIV) can provide ventilatory support in selected patients with acute respiratory failure, for instance due to acute exacerbation of COPD and acute heart failure.
Advantages of noninvasive ventilation compared to invasive mechanical ventilation include absence of complications associated with endotracheal intubation, lower risk of pneumonia, lower level or even absence of sedation and the ability of the patient to verbally communicate.
However, in approximately 30% of patients NIV fails and endotracheal intubation is needed to provide optimal ventilatory support.
Surprisingly, very few studies have investigated why patients fail on NIV.
Clinical observations indicated that agitation, delirium and most importantly asynchrony between patient and ventilator play a role in unsuccessful support with NIV.
The upper airways are bypassed during endotracheal intubation.
However, with NIV the upper airways may play a role in the efficiency of ventilatory support.
In normal breathing the upper airways actively dilate before initiation of inspiratory flow.
This is a highly appropriate response as it prevents narrowing of the upper airways during inspiration, which would result in elevated inspiratory resistance.
Experiments in newborn lambs have shown that NIV has profound effects on physiology of the upper airways.
Positive pressure during inspiration results in constriction of upper airway muscles in the early phase of inspiration.
This results in elevated upper airway resistance with lower tidal volume delivered to the lungs.
Subsequent studies revealed that reflexes that mediate this response originate in vagal afferences located in the lower airways.
From an evolutionary point of view this might be an appropriate response, as high pressure delivered to the lungs may induce barotraumas.
However, these responses may negatively affect the efficiency of ventilatory support delivered during NIV.
The understanding of upper airway constriction and dilation during NIV is rudimentary.
This study aims at determining the effect of NIV on regulation of upper airway patency in patients with COPD.
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Anticipated)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands, 6500HB
- Recruiting
- University Medical Centre Radboud
-
Contact:
- L Heunks, MD PhD
- Phone Number: 0243617273
- Email: l.heunks@ic.umcn.nl
-
Contact:
- E Oppersma, MSc
- Phone Number: 0243617273
- Email: e.oppersma@ic.umcn.nl
-
Principal Investigator:
- L Heunks, MD PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The patient population for this study will be included from the intensive care.
All patients at the intensive care unit who are in clinical need of noninvasive mechanical ventilation due to hypercapnic COPD and with a NAVA catheter in situ, will be screened and asked for informed consent to participate.
Description
Inclusion Criteria:
- Informed consent
- COPD
- Hypercapnic respiratory acidosis
- Clinical need of NIV ventilation on the intensive care
- NAVA catheter in situ
Exclusion Criteria:
- Pre-existent muscle disease (congenital or acquired) or diseases / disorders known to be associated with myopathy including auto-immune diseases.
- Diabetes
- Upper airway/esophageal/mouth or face pathology (i.e. recent surgery, esophageal varices, diaphragmatic hernia)
- Recent (< 1 month) nasal bleeding
- Allergic to xylocaïne
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
COPD patients receiving NIV
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The extent of glottis closure during diaphragm activation and the time delay in glottis opening with respect to diaphragm activity
Time Frame: 1 Day
|
1 Day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Anticipated)
January 1, 2016
Study Registration Dates
First Submitted
February 12, 2013
First Submitted That Met QC Criteria
February 12, 2013
First Posted (Estimate)
February 13, 2013
Study Record Updates
Last Update Posted (Estimate)
June 10, 2015
Last Update Submitted That Met QC Criteria
June 9, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIVGlottis
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Noninvasive Ventilation
-
University of AlbertaWithdrawn
-
Chongqing Medical UniversityCompleted
-
Universitätsklinikum Hamburg-EppendorfActive, not recruitingAirway Management | Noninvasive Ventilation | Mask VentilationGermany
-
Fisher and Paykel HealthcareCompletedHealthy Volunteers | Noninvasive VentilationNew Zealand
-
Hospital San Carlos, MadridHospital Universitario Ramon y Cajal; Hospital Universitario Virgen de la Arrixaca and other collaboratorsCompletedNoninvasive Ventilation | Trophic NutritionSpain
-
University of UtahNational Heart, Lung, and Blood Institute (NHLBI); National Institute of Nursing... and other collaboratorsCompletedNoninvasive Ventilation | Speech IntelligibilityUnited States
-
University Hospital, MontpellierAssociation pour l'Assistance et la Réhabilitation à Domicile (APARD)CompletedNoninvasive Ventilation | Continuous Positive Airway PressureFrance
-
Prince of Songkla UniversityCompletedNewborn Morbidity | Noninvasive Ventilation | High-Frequency Ventilation | Intermittent Positive-Pressure VentilationThailand
-
Guilherme Sant'Anna, MDUnknown
-
University of Missouri-ColumbiaCompletedEffect of Head Rotation on Efficacy of Face Mask Ventilation in Anesthetized Obese (BMI ≥ 35) AdultsNoninvasive VentilationUnited States